EP3690425B1 - Measurement device and measurement method for hematoctrit - Google Patents

Measurement device and measurement method for hematoctrit Download PDF

Info

Publication number
EP3690425B1
EP3690425B1 EP17927545.8A EP17927545A EP3690425B1 EP 3690425 B1 EP3690425 B1 EP 3690425B1 EP 17927545 A EP17927545 A EP 17927545A EP 3690425 B1 EP3690425 B1 EP 3690425B1
Authority
EP
European Patent Office
Prior art keywords
light
irradiator
component
blood
scattered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17927545.8A
Other languages
German (de)
French (fr)
Other versions
EP3690425A1 (en
EP3690425A4 (en
Inventor
Ikuya Kikuchi
Atsuya Ito
Ryohei Kagawa
Tomoya Murakami
Akari Agata
Genki Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Water Biodesign Inc
Nikkiso Co Ltd
Original Assignee
Air Water Biodesign Inc
Nikkiso Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Water Biodesign Inc, Nikkiso Co Ltd filed Critical Air Water Biodesign Inc
Publication of EP3690425A1 publication Critical patent/EP3690425A1/en
Publication of EP3690425A4 publication Critical patent/EP3690425A4/en
Application granted granted Critical
Publication of EP3690425B1 publication Critical patent/EP3690425B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • G01N21/53Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke
    • G01N21/532Scattering, i.e. diffuse reflection within a body or fluid within a flowing fluid, e.g. smoke with measurement of scattering and transmission
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N2021/4704Angular selective
    • G01N2021/4707Forward scatter; Low angle scatter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N2021/4704Angular selective
    • G01N2021/4709Backscatter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N2021/4704Angular selective
    • G01N2021/4711Multiangle measurement
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N2021/4704Angular selective
    • G01N2021/4726Detecting scatter at 90°
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/4738Diffuse reflection, e.g. also for testing fluids, fibrous materials
    • G01N2021/4764Special kinds of physical applications
    • G01N2021/4769Fluid samples, e.g. slurries, granulates; Compressible powdery of fibrous samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/061Sources
    • G01N2201/06113Coherent sources; lasers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood

Definitions

  • FIG. 7 is a plan view illustrating a configuration of the measuring apparatus according to the second practical example.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

    Technical Field
  • The present invention relates to a measuring apparatus and a measuring method that can measure information about a fluid.
  • Background Art
  • For this type of apparatus, there is known an apparatus configured to irradiate fluid with light and to receive scattered light, thereby measuring information about the fluid. In the fluid, irradiation light is scattered in a plurality of directions. If those scattered lights are separately detected, it is considered that the information about the fluid can be measured by using respective properties of the scattered lights (e.g., refer to Patent Literature 1). Patent Literature 2 describes a measuring device for determining hemolysis. The measuring device comprises a transmitter and a receiver arranged opposite of each other and on both sides of a hose line on a common axis. For the detection of scattered radiation, the measuring device contains three further receivers. The Lambert-Beer law describes the relationship between the intensity of the incident light and the emitted light to calculate the hematocrit value in the control and analysis unit. This document discloses the preamble of claim 1.
  • Patent Literature 3 describes a device for measuring a blood constituent in blood for an extracorporeal blood treatment device, comprising a dialyzer or a filter, and a hose line system comprising hose lines that are pervious to electromagnetic radiation.
  • Citation List Patent Literature
    • Patent Literature 1: Japanese Patent No. 4451567
    • Patent Literature 2: JP 2016 540971 A
    • Patent Literature 3: US 2012/031841 A1
    Summary of Invention Technical Problem
  • The scattered light may include not only forward scattered light and backscattered light, but also side scattered light (i.e., light scattered in a direction substantially perpendicular to an optical axis in a surface layer of the fluid). A method of measuring the information about the fluid by using the side scattered light, however, still has room for improvement. For example, in a technology/technique described in the Patent Literature 1, a change in components of the fluid may also change a relation among scatter components. Thus, in the measurement of fluids having different components, measurement precision is significantly reduced, which is technically problematic.
  • The above is an example of problems to be solved by the present invention. It is therefore an object of the present invention to provide a measuring apparatus and a measuring method that can measure the information about the fluid by using the side scattered light.
  • Solution to Problem
  • The invention is defined by the apparatus of appended claim 1 and the method of appended claim 6.
  • Brief Description of Drawings
    • [FIG. 1] FIG. 1 is a plan view illustrating a configuration of a measuring apparatus according to a first practical example.
    • [FIG. 2] FIG. 2 is version 1 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver.
    • [FIG. 3] FIG. 3 is version 2 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver.
    • [FIG. 4] FIG. 4 is a graph illustrating a relation between a transmitted light amount and a side scattered light amount.
    • [FIG. 5] FIG. 5 is a graph illustrating a relation between the transmitted light amount and a backscattered light amount.
    • [FIG. 6] FIG. 6 is a graph illustrating a relation between the transmitted light amount and a sum of the side scattered light amount and the backscattered light amount.
    • [FIG. 7] FIG. 7 is a plan view illustrating a configuration of a measuring apparatus according to a second practical example.
    Description of Embodiments
  • <1> A measuring apparatus according to the invention is provided with:
    an irradiator configured to irradiate fluid with light; a first light receiver configured to receive a forward scatter component of scattered light scattered by the fluid; a second light receiver configured to receive a backscatter component of the scattered light; a third light receiver configured to receive a side scatter component of the scattered light; and an outputting device configured to output fluid information about the fluid, which is obtained on the basis of light receiving signals of the first light receiver, the second light receiver, and the third light receiver.
  • According to the measuring apparatus in the invention, in operation thereof, for example, the fluid that flows in a tubing is irradiated with light by the irradiator. The light irradiated or applied from the irradiator is scattered in the fluid and becomes the scattered light.
  • The scattered light is received by each of the plurality of receivers arranged in different positions. Specifically, the forward scatter component of the scattered light is received by the first light receiver, the backscatter component of the scattered light is received by the second light receiver, and the side scatter component of the scattered light is received by the third light receiver. From the light receiving signals of the first light receiver, the second light receiver, and the third light receiver, the fluid information about the fluid is obtained, and is outputted from the outputting device.
  • In the invention, as described above, at least three scatter components (i.e., the forward scatter component, the backscatter component, and the side scatter component) are used to obtain the fluid information. It is thus possible to output accurate fluid information, in comparison with that when the fluid information is obtained on the basis of only one or two scatter components.
  • Moreover, the fluid in the invention is blood, but the measurement, outside the scope of the present invention, can be also applied to any fluid other than the blood (e.g., ink, oil, wastewater or sewage, a seasoning, etc.).
  • Furthermore, the fluid information in the invention is a ratio of the volume of blood cells or blood corpuscles in the blood (which is a so-called hematocrit value).
  • <2> In the invention, the outputting device is configured to output the fluid information, which is obtained on the basis of a sum of the backscatter component and the side scatter component, and on the basis of the forward scatter component.
  • According to studies by the present inventors, it is found that there is a fixed relation between the sum of the backscatter component and the side scatter component, and the forward scatter component. It is thus possible to output the accurate fluid information, more easily, by using the sum of the backscatter component and the side scatter component, and by using the forward scatter component.
  • <3> In another aspect of the measuring apparatus according to the invention, the irradiator is placed such that an optical axis of irradiation light is diagonal to a direction in which the fluid flows.
  • According to this aspect, since oblique light is applied with respect to the direction in which the fluid flows, it is easy to place the third light receiver configured to receive the side scatter component. It is also easy to detect a Doppler signal.
  • <4> In the aforementioned aspect in which the irradiator is placed such that the optical axis is diagonal, the irradiator may be placed such that the optical axis of the irradiation light is at an angle other than a vicinity of 45 degrees to the direction in which the fluid flows.
  • If the light is irradiated or applied at an angle of the vicinity of 45 degrees to the direction in which the fluid flows, strong scattered light, which includes the backscatter component, enters the third light receiver configured to receive the side scattered light, and it is hardly possible to appropriately receive the side scatter component. If the light is irradiated or applied at the angle other than the vicinity of 45 degrees, the aforementioned detrimental effect can be avoided.
  • <5> In another aspect of the measuring apparatus according to the invention, the irradiator includes a first irradiator and a second irradiator, the first light receiver is configured to receive a forward scatter component of scattered light of the first irradiator; the second light receiver is configured to receive a backscatter component of the scattered light of the first irradiator; and the third light receiver is configured to receive a side scatter component of scattered light of the second irradiator.
  • According to this aspect, the first irradiator for generating the forward scatter component and the backscatter component and the second irradiator for generating the side scatter component are provided, separately. Thus, in comparison with a single irradiator, it is possible to make measurements in the conditions that are suitable for the respective scatter components.
    <6>
  • <7> A measuring method according to the invention is a measuring method provided with: an irradiating process of irradiating fluid with light; a first light receiving process of receiving a forward scatter component of scattered light scattered by the fluid; a second light receiving process of receiving a backscatter component of the scattered light; a third light receiving process of receiving a side scatter component of the scattered light; and an outputting process of outputting fluid information about the fluid, which is obtained on the basis of light receiving signals of the first light receiving process, the second light receiving process, and the third light receiving process.
  • According to the measuring method in the invention, as in the measuring apparatus described above, at least three scatter components are used to obtain the fluid information. It is thus possible to output the accurate fluid information, in comparison with that when the fluid information is obtained on the basis of only one or two scatter components.
  • <8> The effect and other benefits of the measuring apparatus, the measuring method according to the invention will be explained in more detail in practical examples below.
  • Practical Examples
  • Hereinafter, a measuring apparatus according to practical examples will be explained in detail with reference to the drawings. In the following, an explanation will be given to a situation in which the measuring apparatus is applied to an apparatus for measuring the concentration (or a hematocrit value) of blood that flows in a tubing that constitutes a blood circuit of an artificial dialysis apparatus.
  • <First Practical Example>
  • Firstly, a configuration of the measuring apparatus according to a first practical example will be explained with reference to FIG. 1. FIG. 1 is a plan view illustrating the configuration of the measuring apparatus according to the first practical example.
  • As illustrated in FIG. 1, the measuring apparatus according to the first practical example is configured as an apparatus for measuring a hematocrit value of blood by irradiating the blood that flows in a tubing 300, with light. The measuring apparatus is provided with an irradiator 100, a first light receiver 210, a second light receiver 220, a third light receiver 230, and a blood information processor 400.
  • The irradiator 100 is configured, for example, as a laser light source, and is configured to irradiate the blood that flows in the tubing 300, with light. The irradiator 100 is placed such that an optical axis of irradiation light is an angle of θ1 to a direction in which the blood flows (i.e., a flow axis in FIG. 1). θ1 may be an angle other than the vicinity of 90 degrees and the vicinity of 45 degrees. The reason of avoiding setting θ1 in the vicinity of 90 degrees is to facilitate the placement of the third light receiver 230 described later. The reason of avoiding setting θ1 in the vicinity of 45 degrees is to prevent strong scattered light, which includes a backscatter component, from entering the third light receiver 230 described later.
  • The first light receiver 210 is placed in a position in which it can receive a component that passes through the blood (i.e., a forward scatter component), out of light scattered by the blood that flows in the tubing 300. Specifically, the first light receiver 210 is placed in a position opposite to the irradiator 100, as viewed from the tubing 300. The first light receiver 210 is configured to output a signal corresponding to the received forward scatter component, to the blood information processor 400.
  • The second light receiver 220 is placed in a position in which it can receive a component that is scattered in a direction of the position of the irradiator 100 (i.e., a backscatter component), out of the light scattered by the blood that flows in the tubing 300. Specifically, the second light receiver 220 is placed in a position extremely close to the irradiator 100. The second light receiver 220 is configured to output a signal corresponding to the received backscatter component, to the blood information processor 400.
  • The third light receiver 230 is placed in a position in which it can receive a component that is scattered in a direction that is different from the direction of the position of the irradiator 100 (i.e., a side scatter component), out of the light scattered by the blood that flows in the tubing 300. Specifically, the third light receiver 230 is placed in a direction at an angle of θ2 to the optical axis of irradiation light. θ2 is in the vicinity of 90 degrees.
  • The blood information processor 400 is configured to arithmetically operate and output blood information (which is herein the hematocrit value of the blood), on the basis of the light receiving signals inputted from the first light receiver 210, the second light receiver 220, and the third light receiver 230. A method of arithmetically operating the blood information will be detailed later.
  • For convenience of explanation, in FIG. 1, a positional relation of the light receivers is illustrated, two-dimensionally, but the light receivers may be arranged, three-dimensionally. Hereinafter, a three-dimensional arrangement of the first light receiver 210, the second light receiver 220, and the third light receiver 230 will be explained with reference to FIG. 2 and FIG. 3. FIG. 2 is version 1 of a cross sectional view illustrating a plurality of scatter components of the irradiation light and a placement location of each light receiver. FIG. 3 is version 2 of a cross sectional view illustrating a plurality of scatter components of irradiation light and a placement location of each light receiver.
  • Each of coordinate axes in FIG. 2 and FIG. 3 corresponds to a coordinate axis in FIG. 1. In other words, FIG. 2 is a cross sectional view in a direction in which the blood flows from a left side to a right side in the drawing. FIG. 3 is a cross sectional view in a direction in which the blood flows from a far side to a near side in the drawing.
  • As illustrated in FIG. 2 and FIG. 3, each of various components of the scattered light (i.e., the forward scatter component, the backscatter component, and the side scatter component) spreads from a scattering point (which is specifically a surface layer of the blood), three-dimensionally and radially. Thus, even when the first light receiver 210, the second light receiver 220, and the third light receiver 230 are arranged, three-dimensionally, as illustrated in FIG. 2 and FIG. 3, the light receivers can receive the respective scatter components. This three-dimensional arrangement increases the degree of freedom of an arrangement layout of the light receivers.
  • Next, a relation among the scatter components and a resulting problem thereof will be explained with reference to FIG. 4 and FIG. 5. FIG. 4 is a graph illustrating a relation between a transmitted light amount and a side scattered light amount. FIG. 5 is a graph illustrating a relation between the transmitted light amount and a backscattered light amount.
  • As illustrated in FIG. 4, a relation between an amount of light received by the first light receiver 210 (hereinafter referred to a "transmitted light amount" as occasion demands) and an amount of light received by the third light receiver 230 (hereinafter referred to a "side scattered light amount" as occasion demands) changes between when protein concentration in blood plasma in the blood is high and when it is low. Specifically, when the protein concentration in the blood plasma changes, a relation between a logarithm of the transmitted light amount (Log transmitted light amount) and the side scattered light amount linearly changes. At this time, a slope of a straight line varies depending on the type of the blood. As is clear from the drawing, a slope of a straight line of the blood A is clearly different from that of the blood B.
  • As illustrated in FIG. 5, a relation between the amount of the light received by the first light receiver 210 (i.e., the transmitted light amount) and an amount of light received by the second light receiver 220 (hereinafter referred to a "backscattered light amount" as occasion demands) also changes between when the protein concentration in the blood plasma in the blood is high and when it is low. Specifically, when the protein concentration in the blood plasma changes, a relation between the logarithm of the transmitted light amount (Log transmitted light amount) and the backscattered light amount linearly changes. At this time, a slope of a straight line varies depending on the type of the blood. As is clear from the drawing, a slope of a straight line of the blood A is clearly different from that of the blood B.
  • The results in FIG. 4 and FIG. 5 may mean that the hematocrit value cannot be accurately measured from the transmitted light amount and the side scattered light amount, or from the transmitted light amount and the backscattered light amount. In order to solve the problem, the measuring apparatus according to the first practical example is configured to calculate the hematocrit value by using the three types of scatter components.
  • Next, a method of deriving the hematocrit value by the measuring apparatus according to the first practical example will be explained with reference to FIG. 6. FIG. 6 is a graph illustrating a relation between the transmitted light amount and a sum of the side scattered light amount and the backscattered light amount (or an average value of the side scattered light amount and the backscattered light amount).
  • As illustrated in FIG. 6, according to studies by the present inventors, it is found that there is a fixed relation between the transmitted light amount and the sum of the side scattered light amount and the backscattered light amount. Specifically, when the transmitted light amount is L1, the side scattered light amount is L2, and the backscattered light amount, the following relation is established. α × L 2 + β × L 3 LogL 1 : α × β 0 ,
    Figure imgb0001
    wherein α and β are predetermined gain coefficients.
  • As a result, by measuring each of the transmitted light amount, the side scattered light amount, and the backscattered light amount, the hematocrit value can be arithmetically operated by using the above relation. The hematocrit value may be arithmetically operated by using a predetermined mathematical expression, or may be determined by preparing a map as illustrated in FIG. 6 in advance.
  • For example, when the transmitted light amount (i.e., LogL1) is A, if the sum of the side scattered light amount and the backscattered light amount (i.e., (α×L2+β×L3)/2) is a, then, the hematocrit value can be determined to be Hct=50. When the transmitted light amount (i.e., LogL1) is A, if the sum of the side scattered light amount and the backscattered light amount (i.e., (α×L2+β×L3)/2) is b, then, the hematocrit value can be determined to be Hct=40.
  • As explained above, according to the measuring apparatus in the first practical example, it is possible to arithmetically operate an accurate hematocrit value, by measuring each of the transmitted light amount (i.e., the forward scatter component of the scattered light), the side scattered light amount (i.e., the side scatter component of the scattered light), and the backscattered light amount (i.e., the backscatter component of the scattered light).
  • <Second Practical Example>
  • Next, a measuring apparatus according to a second practical example will be explained with reference to FIG. 7. FIG. 7 is a plan view illustrating a configuration of the measuring apparatus according to the second practical example.
  • The second practical example is partially different in configuration from the first practical example described above, and is substantially the same in other part. Thus, hereinafter, only a different part from the first practical example will be explained in detail, and an explanation of the same part will be omitted, as occasion demands.
  • As illustrated in FIG. 7, the measuring apparatus according to the second practical example is provided with two irradiators (which are specifically a first irradiator 110 and a second irradiator 120).
  • The first irradiator 110 is configured to apply light for measuring the transmitted light amount and the backscattered light amount. Thus, the first light receiver 210, which is configured to receive the forward scatter component, is placed opposite to the first irradiator 110, as viewed from the tubing 300, and the second light receiver 220, which is configured to receive the backscatter component, is placed extremely close to the first irradiator 110.
  • The second irradiator 120 is configured to apply light for measuring the side scattered light amount. Thus, the second irradiator 120 is placed such that an optical axis of irradiation light is an angle of θ1 to a direction in which the blood flows (i.e., a flow axis). Moreover, the third light receiver 230 is placed in a direction at an angle of θ2 to the optical axis of the light applied by the second irradiator 120.
  • According to the measuring apparatus in the second practical example, the provision of the two irradiators makes it possible to realize measurement conditions corresponding to the respective scatter components. Specifically, by placing the first irradiator 110 such that the light applied by the first irradiator 110 enters substantially perpendicular to the flow axis while diagonally setting the optical axis of the second irradiator 120 for measuring the side scattered light amount, it is possible to narrow a scattering range of the transmitted light, in comparison with that when the optical axis of the first irradiator 110 is diagonally set, so that it is possible to miniaturize the first irradiator 110.
  • The present invention is not limited to the aforementioned embodiments and examples, but various changes may be made, if desired, without departing from the scope of the invention as defined by the appended claims.
  • Description of Reference Numerals and Letters
  • 100
    irradiator
    110
    first irradiator
    120
    second irradiator
    210
    first light receiver
    220
    second light receiver
    230
    third light receiver
    300
    tubing
    400
    blood information processor

Claims (6)

  1. A measuring apparatus comprising:
    an irradiator (100) configured to irradiate blood with light;
    a first light receiver (210) configured to receive a forward scatter component of scattered light scattered by the blood;
    a second light receiver (220) configured to receive a backscatter component of the scattered light;
    a third light receiver (230) configured to receive a side scatter component of the scattered light; and
    an outputting device (400) configured to output hematocrit value of the blood, characterised in that:
    the hematocrit value
    is obtained on the basis of light receiving signals of said first light receiver (210), said second light receiver (220), and said third light receiver (230),
    wherein said outputting device (400) is configured to determine the hematocrit value using a relationship between the sum of the backscatter component and the side scatter component, and the forward scatter component.
  2. The measuring apparatus according to claim 1, wherein said outputting device (400) is configured to determine the hematocrit value using the proportional relationship between the sum of the backscatter component and side scatter component, and the logarithm of the forward scatter component.
  3. The measuring apparatus according to claim 1 or 2, wherein said irradiator (100) is placed such that an optical axis of irradiation light is diagonal to a direction in which the blood flows.
  4. The measuring apparatus according to claim 3, wherein said irradiator (100) is placed such that the optical axis of the irradiation light is at an angle other than a vicinity of 45 degrees to the direction in which the blood flows.
  5. The measuring apparatus according to any of claims 1 to 4, wherein
    said irradiator (100) includes a first irradiator (110) and a second irradiator (120),
    said first light receiver (210) is configured to receive a forward scatter component of scattered light of the first irradiator (110);
    said second light receiver (220) is configured to receive a backscatter component of the scattered light of the first irradiator (110); and
    said third light receiver (230) is configured to receive a side scatter component of scattered light of the second irradiator (120).
  6. A measuring method comprising:
    an irradiating process of irradiating blood with light;
    a first light receiving process of receiving a forward scatter component of scattered light scattered by the blood;
    a second light receiving process of receiving a backscatter component of the scattered light;
    a third light receiving process of receiving a side scatter component of the scattered light; and
    an outputting process of outputting hematocrit value of the blood,
    characterised in that:
    the hematocrit value I is obtained on the basis of light receiving signals of said first light receiving process, said second light receiving process, and said third light receiving process,
    wherein said outputting process is configured to determine the hematocrit value using a relationship between the sum of the backscatter component and the side scatter component, and the forward scatter component.
EP17927545.8A 2017-09-29 2017-09-29 Measurement device and measurement method for hematoctrit Active EP3690425B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2017/035678 WO2019064559A1 (en) 2017-09-29 2017-09-29 Measurement device, measurement method, computer program, and storage medium

Publications (3)

Publication Number Publication Date
EP3690425A1 EP3690425A1 (en) 2020-08-05
EP3690425A4 EP3690425A4 (en) 2021-05-19
EP3690425B1 true EP3690425B1 (en) 2023-07-19

Family

ID=65902502

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17927545.8A Active EP3690425B1 (en) 2017-09-29 2017-09-29 Measurement device and measurement method for hematoctrit

Country Status (4)

Country Link
US (1) US11209359B2 (en)
EP (1) EP3690425B1 (en)
JP (1) JP6858875B2 (en)
WO (1) WO2019064559A1 (en)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2815435B2 (en) * 1989-12-22 1998-10-27 株式会社日立製作所 Particle analyzer and blood cell counter
US5506679A (en) * 1994-09-08 1996-04-09 Hach Company Nephelometer instrument
JP3446410B2 (en) * 1995-07-24 2003-09-16 株式会社島津製作所 Laser diffraction particle size distribution analyzer
JP3371816B2 (en) * 1998-07-31 2003-01-27 株式会社島津製作所 Particle concentration measuring method and device and particle measuring device
SE9804142D0 (en) 1998-11-30 1998-11-30 Gambro Ab Method and device for providing a signal
US6519034B1 (en) * 1998-12-16 2003-02-11 Honeywell International Inc. Oil quality sensor
US6567166B2 (en) * 2001-02-21 2003-05-20 Honeywell International Inc. Focused laser light turbidity sensor
US6798508B2 (en) * 2002-08-23 2004-09-28 Coulter International Corp. Fiber optic apparatus for detecting light scatter to differentiate blood cells and the like
US6743634B2 (en) * 2002-08-23 2004-06-01 Coulter International Corp. Method and apparatus for differentiating blood cells using back-scatter
DE10330641A1 (en) * 2003-07-07 2005-02-03 Basf Coatings Ag High-precision remission sensor for wet measurement of paints and pigment pastes
WO2005116636A1 (en) * 2004-05-25 2005-12-08 Renner Herrmann S.A. An apparatus and method for measuring the spectral properties of a fluid
US7390662B2 (en) * 2005-11-09 2008-06-24 Beckman Coulter, Inc. Method and apparatus for performing platelet measurement
DE102006029899B4 (en) * 2006-06-29 2009-06-04 Fresenius Medical Care Deutschland Gmbh Spectroscopic detector and method for the determination of blood and biological markers in liquids
ES2796655T3 (en) * 2008-11-14 2020-11-27 Beckman Coulter Inc Monolithic Optical Flow Cells and Manufacturing Method
DE102009017304A1 (en) * 2009-04-11 2010-10-21 Fresenius Medical Care Deutschland Gmbh Apparatus and method for measuring a blood component in blood for an extracorporeal blood treatment device
US7973923B2 (en) * 2009-04-27 2011-07-05 Endress+Hauser Conducta Inc. Multi-port inline flow cell for use in monitoring multiple parameters in a sanitary process line
WO2013114333A1 (en) * 2012-02-04 2013-08-08 Centre For Cellular And Molecular Platforms (C-Camp) Microfluidic flow analyzer for pathological detection and method thereof
US9372143B2 (en) * 2013-05-15 2016-06-21 Captl Llc Scanning image flow cytometer
DE102013018284B4 (en) 2013-10-31 2015-08-27 Fresenius Medical Care Deutschland Gmbh Method and device for detecting hemolysis or for determining a correction factor which corrects the influence of hemolysis on a measurement of the hematocrit
KR20190045340A (en) * 2016-09-13 2019-05-02 바스프 코팅스 게엠베하 A sensor for measuring the permeation and / or forward scattering and / or re-emission substantially simultaneously and for simultaneously measuring the permeation and forward scattering or transmission and re-emission of the liquid sample
IT201700073456A1 (en) * 2017-06-30 2018-12-30 Eos S R L Method for characterization of objects by analysis of diffuse radiation and related instrumentation.

Also Published As

Publication number Publication date
US11209359B2 (en) 2021-12-28
JP6858875B2 (en) 2021-04-14
WO2019064559A1 (en) 2019-04-04
EP3690425A1 (en) 2020-08-05
EP3690425A4 (en) 2021-05-19
JPWO2019064559A1 (en) 2020-10-15
US20200264100A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
US8054452B2 (en) Spectroscopic detector and method for determining the presence of blood and biological marker substances in liquids
EP3001174B1 (en) Blood analyzer and blood analyzing method
US6525807B1 (en) Particle analyzing apparatus
EP1579196B1 (en) Method and device for measurements in blood
EP3803330A1 (en) Analysis apparatus and method for analyzing a viscosity of a fluid
EP3111211B1 (en) Self calibrating blood chamber
JP6604611B2 (en) Non-invasive biological lipid measuring instrument and non-invasive biological lipid measuring method
CN208905860U (en) Detection device for the medium in pipe section and the Medical Devices including it
CN105716680A (en) Apparatus for determining a value that represents the amount of a liquid and its use
WO2005028001A1 (en) An apparatus, a system and a method relating to hemodialysis, hemodiafiltration, hemofiltration or peritoneal dialysis
US9551659B2 (en) Optical apparatus and method for fluorescence measurement of analytes comprising backscattering detection
EP3690425B1 (en) Measurement device and measurement method for hematoctrit
ITMI20090926A1 (en) SYSTEM AND METHOD FOR SPECTROPHOTOMETRIC MEASUREMENTS OF BLOOD PARAMETERS.
US20160271318A1 (en) Method and apparatus for detecting hemolysis or for determining a correction factor to correct the influence of hemolysis on a measurement of hematocrit
WO1987003091A1 (en) A method and apparatus for detecting the concentration of contaminants in a liquid
Schwarz et al. Investigations on the capability of the statistical extinction method for the determination of mean particle sizes in concentrated particle systems
JP7175435B2 (en) Flow velocity identification device
JP7285503B2 (en) TOTAL PROTEIN MEASUREMENT DEVICE AND TOTAL PROTEIN MEASUREMENT METHOD
EP3017292A1 (en) Method for determining the concentration of a substance in a deformable container
JP2016523373A5 (en)
JP4793413B2 (en) Differential refractive index detector
JP7344396B2 (en) Water quality sensor and method for measuring substance concentration in water
CN118159829A (en) Multi-wavelength ozone concentration sensor and use method thereof
Martínez et al. Unclassified green dots on nucleated red blood cells (nRBC) plot in DxH900 from a patient with hyperviscosity syndrome
JPH05142236A (en) Optical measuring apparatus

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602017071664

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: G01N0021490000

Ipc: G01N0021530000

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: G01N0021490000

Ipc: G01N0021530000

A4 Supplementary search report drawn up and despatched

Effective date: 20210421

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 21/53 20060101AFI20210415BHEP

Ipc: G01N 33/487 20060101ALI20210415BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NIKKISO COMPANY LIMITED

Owner name: AIR WATER BIODESIGN INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20230214

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230414

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017071664

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20230719

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1589938

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231020

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231120

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231019

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231119

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231020

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017071664

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230929

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20230930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230929

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

26N No opposition filed

Effective date: 20240422

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230929

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230930

REG Reference to a national code

Ref country code: SE

Ref legal event code: RPOT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230929

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230930

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230719

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230930

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240806

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240808

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20240808

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20240812

Year of fee payment: 8

Ref country code: IT

Payment date: 20240812

Year of fee payment: 8